ClearPoint Neuro, Inc.
General ticker "CLPT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $409.6M (TTM average)
ClearPoint Neuro, Inc. follows the US Stock Market performance with the rate: 34.4%.
Estimated limits based on current volatility of 4.0%: low 14.27$, high 15.46$
Factors to consider:
- Total employees count: 115 (+7.5%) as of 2024
- Top business risk factors: Economic downturns and volatility, Customer concentration, Manufacturing disruptions, Cybersecurity threats, Acquisition/divestiture risks
- Current price 11.3% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.25$, 19.28$]
- 2025-12-31 to 2026-12-31 estimated range: [4.69$, 13.17$]
Financial Metrics affecting the CLPT estimates:
- Positive: with PPE of -22.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.15 <= 0.04
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 64.79 > 64.17
- Positive: Investing cash flow per share per price, % of -0.07 > -0.62
- Positive: Inventory ratio change, % of -4.99 <= -0.76
- Positive: Industry inventory ratio change (median), % of -1.22 <= -0.18
Short-term CLPT quotes
Long-term CLPT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $20.55MM | $23.95MM | $31.39MM |
| Operating Expenses | $36.88MM | $46.40MM | $51.14MM |
| Operating Income | $-16.33MM | $-22.45MM | $-19.75MM |
| Non-Operating Income | $-0.10MM | $0.36MM | $0.83MM |
| R&D Expense | $10.89MM | $11.71MM | $12.39MM |
| Income(Loss) | $-16.43MM | $-22.09MM | $-18.91MM |
| Profit(Loss)* | $-16.44MM | $-22.09MM | $-18.91MM |
| Stockholders Equity | $36.89MM | $21.17MM | $25.39MM |
| Inventory | $9.30MM | $7.91MM | $6.86MM |
| Assets | $55.49MM | $42.66MM | $39.19MM |
| Operating Cash Flow | $-16.17MM | $-13.72MM | $-8.95MM |
| Capital expenditure | $0.25MM | $0.72MM | $0.28MM |
| Investing Cash Flow | $-10.74MM | $8.95MM | $-0.28MM |
| Financing Cash Flow | $0.41MM | $0.30MM | $6.19MM |
| Earnings Per Share** | $-0.68 | $-0.90 | $-0.70 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.